NEUROCRINE BIOSCIENCES INC Inventory, Finished Goods, Net of Reserves
NEUROCRINE BIOSCIENCES INC (NBIX) had Inventory, Finished Goods, Net of Reserves of $10.40 million as of 2023-09-30, per its 10-Q filed 2023-10-31.
Discontinued › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2023-10-31
- 2023-09-30: Inventory, Finished Goods, Net of Reserves $10.40M.
- 2023-06-30: Inventory, Finished Goods, Net of Reserves $15.00M.
- 2023-03-31: Inventory, Finished Goods, Net of Reserves $18.00M.
- 2022-12-31: Inventory, Finished Goods, Net of Reserves $17.50M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2023-09-30 | $10.40M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $15.00M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $18.00M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $17.50M 10-Q · filed 2023-10-31 | |
| 2022-09-30 | $17.00M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $17.90M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $15.40M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $15.70M 10-K · filed 2023-02-09 | |
| 2021-09-30 | $11.20M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $11.50M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $12.80M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $9.00M 10-K · filed 2022-02-11 | |
| 2020-09-30 | $4.80M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.40M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $2.30M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.70M 10-K · filed 2021-02-05 | $1.67M 10-K · filed 2020-02-07 |
| 2019-09-30 | $2.09M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $1.90M 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $819.00K 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $801.00K 10-K · filed 2020-02-07 | |
| 2018-09-30 | $1.01M 10-Q · filed 2018-11-05 | |
| 2017-12-31 | $533.00K 10-K · filed 2019-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |